← Browse by Condition
Medical Condition
colon adenocarcinoma
Total Trials
3
Recruiting Now
3
Trial Phases
Phase 2, Phase 3
NCT06640166 Phase 2
Recruiting
Encorafenib + Cetuximab Beyond Progression in Combination With FOLFIRI in Patients With BRAF V600E Mutated Metastatic Colorectal Cancer Progressing on Encorafenib + Cetuximab.
Enrollment
25 pts
Location
Italy
Sponsor
Fondazione Policlinico Univers...
NCT06703632
Recruiting
Evaluation of PreveCol's Efficiency As a Second Line Method for the Early Colorectal Cancer Detection
Enrollment
4,538 pts
Location
Portugal, Spain
Sponsor
ADVANCED MARKER DISCOVERY S.L.
NCT05482516 Phase 3
Recruiting
Evaluating Novel Therapies in ctDNA Positive GI Cancers
Enrollment
20 pts
Location
United States
Sponsor
Georgetown University